
US President Donald Trump announced on Tuesday that generic drugs imported into the United States will face a phased tariff schedule starting from August 1, 2026. The tariffs will begin at 0% for the first two years, increase to 100% for the following year, and then rise to 200% thereafter.
Trump made the announcement on his social media platform, Truth Social, stating that the measure aims to encourage the production of generic drugs within the United States. "This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them," Trump wrote.
The policy is part of a broader effort by the Trump administration to boost domestic manufacturing and reduce reliance on imports. According to the US Food and Drug Administration, more than 90% of medicines sold in the US are generics.
The announcement comes amid ongoing trade tensions between the US and other countries. Canada, for instance, has canceled a joint bridge-opening event with the US in response to Trump's new tariffs on certain Canadian goods. Canadian Prime Minister Mark Carney stated that Canada is evaluating all options following the US threat to impose new tariffs.
Trump's decision to impose tariffs on generic drugs follows an executive order signed in April, which imposed 100% tariffs on branded pharmaceuticals imported into the US unless manufacturers agree to government drug pricing deals or commit to making their products domestically.
The policy on patented, branded, or innovative drugs will remain unchanged, Trump said. The world's biggest drugmakers signed deals with the US government last year that exempted billions of dollars of drugs from tariffs.
The tariffs on generic drugs are set to go into effect in August 2028, with the initial two-year period of zero tariffs starting from August 1, 2026.
Follow us for live European news
7 further sources not geolocated